The addition of glucocorticoids to interferon alfa therapy did not significantly increase the percentage of patients with a treatment response, 39 although low-to-intermediate doses of glucocorticoids ...
The treatment of autoimmune hepatitis is evolving as the pathogenic pathways that underlie the disease are defined, new immunosuppressive agents are tested, and site-specific molecular interventions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback